肝门部胆管癌三维可视化诊治平台的构建及临床应用研究
[Abstract]:Background the incidence of hilar cholangiocarcinoma is on the rise. Surgical resection is the most important method in the treatment of hilar cholangiocarcinoma. In recent years, with the development of digital medicine technology and the promotion and practice of three-dimensional visualization accurate diagnosis and treatment, 3D visualization technology and 3D printing technology are applied more and more in the field of medicine at home and abroad. 3D visualization model is helpful for accurate diagnosis of hilar cholangiocarcinoma, preoperative evaluation and accurate operation, which is gradually accepted by hepatobiliary surgeons. Objective: 1. To optimize the method of abdominal enhanced CT scanning to obtain high quality submillimeter helical CT data of hepatic hilar tumors. 2. The 3D reconstruction method based on surface rendering and volume rendering is studied to construct the 3D visualization model of hilar cholangiocarcinoma quickly and qualitatively. (3) to construct a three-dimensional visual diagnosis and treatment platform for hilar cholangiocarcinoma, to establish the management process of the platform and to discuss its clinical significance; (4) to explore the clinical application value and significance of three-dimensional visualization technique in preoperative evaluation of surgical treatment of hilar cholangiocarcinoma. Methods: the CT data of patients with hilar cholangiocarcinoma were obtained by retrospective case analysis, the 3D visualization model of abdominal medical image was constructed, the procedure of 3D visualization diagnosis and treatment platform was established and its clinical significance was discussed. To evaluate the clinical value and significance of three-dimensional visualization technique in preoperative evaluation of surgical treatment of hilar cholangiocarcinoma. Statistical analysis: the morphologic changes and the results of surgery and pathology (gold standard) were examined by 蠂 2 test, and the mean 卤standard deviation was used to show the measurement data according to the normal distribution. SpSS19.0 statistical APP was selected to analyze all the original data. Results: 1. Acquiring high quality submillimeter CT data and constructing three-dimensional model can clearly reproduce the characteristics of hepatic hilar anatomical structure and successfully construct a three-dimensional visual diagnosis and treatment platform for hilar cholangiocarcinoma. 2. Under the guidance of 3D visualization, the clinical classification, resectability evaluation and preoperative planning of hilar cholangiocarcinoma were carried out, especially in the case of intrahepatic duct variation, the operative planning was guided, and the treatment plan was determined, so as to guide the actual operation during the operation. The results of individualized vessel classification of hilar cholangiocarcinoma guided by three-dimensional visualization were consistent with intraoperative exploration. Conclusion: 1. High-quality submillimeter CT data can provide high resolution imaging features of human abdominal organs and blood vessels and meet the requirements of 3D model data segmentation and 3D reconstruction. 2. The 3D model of hepatic hilar tumor can make accurate and systematic diagnosis of the shape and location of the tumor and the spatial anatomical relationship of the hepatic ducts, and instruct the surgeon to evaluate the resectability of the tumor. 3. The workflow of the three-dimensional visual diagnosis and treatment platform for hilar tumor patients is reasonable and has the value of clinical application demonstration. 4. For patients with hilar cholangiocarcinoma, three dimensional visualization technique was used to optimize the operation path by preoperative operation planning. Especially in the presence of intrahepatic bile duct or vascular variation, preoperative observation of three-dimensional visual model can effectively avoid iatrogenic injury, in order to achieve preoperative accurate diagnosis and treatment of an innovative method, has a certain clinical application value and prospects.
【学位授予单位】:南方医科大学
【学位级别】:博士
【学位授予年份】:2017
【分类号】:R735.8
【相似文献】
相关期刊论文 前10条
1 孙凤林,雷树林,杨常印;外科治疗肝门部胆管癌8例报告[J];山东医药;2000年10期
2 陈钟,李厚祥,陈玉泉;影响肝门部胆管癌切除因素的探讨[J];江苏医药;2000年01期
3 王炳生,刘厚宝,陆维琪,姚礼庆,童赛雄;肝门部胆管癌55例的诊断和治疗[J];中华普通外科杂志;2000年10期
4 汪家坤,王新民,陈孝平;肝门部胆管癌66例诊治分析[J];中国解剖与临床;2000年01期
5 曹树立;肝门部胆管癌[J];宁波医学;2000年02期
6 王人颢,路逵阳,沈士刚,刘斌,王明才,何东升;肝门部胆管癌35例分析[J];徐州医学院学报;2000年06期
7 范正军,吴阳,王陆林,谢志征;73例肝门部胆管癌诊疗体会[J];中国医刊;2000年03期
8 石景森,何平;肝门部胆管癌的诊断[J];肝胆外科杂志;2001年02期
9 詹银楚,余耀生,徐集麟,徐铁铮;肝门部胆管癌21例的治疗体会[J];肝胆外科杂志;2001年02期
10 张琴,张一楚;肝门部胆管癌的根治性切除及生存的预测指标[J];国外医学.外科学分册;2001年01期
相关会议论文 前10条
1 曹利平;彭淑牖;;努力提高肝门部胆管癌的切除率——附64例报告[A];中国抗癌协会胆道肿瘤专业委员会成立大会暨第一届全国胆道肿瘤学术会议论文集[C];2009年
2 牟洪超;姜小清;;肝门部胆管癌26例手术治疗[A];中国抗癌协会胆道肿瘤专业委员会成立大会暨第一届全国胆道肿瘤学术会议论文集[C];2009年
3 ;肝门部胆管癌[A];中国抗癌协会胆道肿瘤专业委员会成立大会暨第一届全国胆道肿瘤学术会议论文集[C];2009年
4 牟洪超;姜小清;;肝门部胆管癌38例临床分析[A];中国抗癌协会胆道肿瘤专业委员会第二届全国胆道肿瘤学术会议论文集[C];2011年
5 仇毓东;毛谅;;肝门部胆管癌的外科治疗[A];中国抗癌协会胆道肿瘤专业委员会第二届全国胆道肿瘤学术会议论文集[C];2011年
6 吴东德;;肝门部胆管癌外科综合治疗与手术分享[A];湖北省抗癌协会青年委员会第五届青年学术论坛资料汇编[C];2013年
7 殷晓煜;;肝门部胆管癌手术治疗的几个重要问题[A];第二届广东肝胆胰疾病防治论坛论文汇编[C];2012年
8 郑树森;;肝门部胆管癌外科治疗进展[A];2013年浙江省外科学学术年会论文汇编[C];2013年
9 吴益夫;方建明;王军保;张惠中;;联合肝胰十二指肠切除术治疗肝门部胆管癌(附3例报告)[A];2013年浙江省外科学学术年会论文汇编[C];2013年
10 姜小清;易滨;罗祥基;刘辰;谭蔚锋;张柏和;吴孟超;;肝门部胆管癌的外科治疗——单个治疗组10年经验[A];中国抗癌协会胆道肿瘤专业委员会成立大会暨第一届全国胆道肿瘤学术会议论文集[C];2009年
相关重要报纸文章 前6条
1 解放军总医院肝胆外科 梁斌 王宏光 项灿宏;肝门部胆管癌 术前评估要做足[N];健康报;2013年
2 通讯员 柳辉艳 记者 程守勤;亚洲首例联合疗法治肝门部胆管癌获成功[N];健康报;2013年
3 本报记者 李颖邋 通讯员 莫鹏;高难度肝门部胆管癌手术成功[N];科技日报;2007年
4 陈厚立;化风险为平夷[N];大众卫生报;2002年
5 莫鹏;二炮总医院成功实施肝门部胆管癌手术[N];中国医药报;2008年
6 本报记者 龚翔;让临床诊治更规范科学[N];中国医药报;2013年
相关博士学位论文 前10条
1 赵传宗;MMP-9的高表达和术前选择性减黄对肝门部胆管癌预后影响的相关研究[D];山东大学;2015年
2 余健;肝门部胆管癌术后生存影响因素分析[D];浙江大学;2016年
3 齐卫鹏;联合血管切除重建在肝门部胆管癌根治术中的应用[D];华中科技大学;2016年
4 曾宁;肝门部胆管癌三维可视化诊治平台的构建及临床应用研究[D];南方医科大学;2017年
5 蔡文科;肝门部胆管癌危险、预后因素分析及不同术式对其之疗效研究[D];第二军医大学;2011年
6 刘炎锋;肝癌衍生生长因子在肝门部胆管癌恶性生物学行为中的研究[D];山东大学;2012年
7 周敏;肝门部胆管癌可切除性评估以及建立预后评估模型[D];浙江大学;2015年
8 李成刚;肝门部胆管癌神经浸润的临床病理学研究[D];中国人民解放军军医进修学院;2008年
9 张复波;黄疸状态下肝门部胆管癌肝切除术后肝功能不全定义及安全标准化残肝体积公式的验证[D];南开大学;2014年
10 钟海钢;肝门部胆管癌根治术后复发高危因素研究[D];浙江大学;2015年
相关硕士学位论文 前10条
1 彭峗杰;肝门部胆管癌57例诊治分析[D];新疆医科大学;2010年
2 刘小红;肝门部胆管癌的治疗进展[D];兰州大学;2011年
3 崔雄俭;肝门部胆管癌的临床特点及其预后相关性分析[D];中南大学;2011年
4 王春芳;肝门部胆管癌的外科治疗[D];兰州大学;2011年
5 张宗义;胆管癌切除联合I~(125)粒子植入治疗肝门部胆管癌的临床研究[D];新乡医学院;2015年
6 李会星;进展期肝门部胆管癌的治疗策略及预后相关因素分析[D];中国人民解放军医学院;2015年
7 宁家勇;Bismuth-Corlette Ⅰ、Ⅱ型肝门部胆管癌的诊治及预后分析[D];山西医科大学;2015年
8 孙延雷;肝门部胆管癌外科治疗的预后分析[D];山东大学;2015年
9 郭剑;营养风险筛查表(NRS2002)应用于肝门部胆管癌营养评估可行性的初步研究[D];山西医科大学;2016年
10 马有钊;肝门部胆管癌不同姑息性治疗方法的对比[D];吉林大学;2016年
,本文编号:2353165
本文链接:https://www.wllwen.com/shoufeilunwen/yxlbs/2353165.html